Administrative title: CEO, James Cancer Hospital and Solove Research Institute; Director, OSU Comprehensive Cancer Center
Clinical interests: Leukemia and lymphoma
Research interests: Dr. Caligiuri’s research focuses on the molecular biology of leukemia, vaccine development to prevent lymphoma, and natural killer cell biology
Medical School: Stanford University School of Medicine
Residency: Brigham and Women’s Hospital at Harvard Medical School
Fellowship: Dana-Farber Cancer Institute at Harvard Medical School
Phone numbers: (614) 293-7521/(614) 293-7523
Click here to view Dr. Caligiuri's Curriculum Vitae.